Publications

Systematic Review Epublish 24 citations
Electronic publication date
June 25, 2021

View on Pubmed.gov 34149692 | View on doi.org 10.3389/fimmu.2...

Immunothrombosis in Acute Respiratory Dysfunction of COVID-19.

Search for publications in this journal Front Immunol

  • Xiang-Zhi Fang

    Search for this expert
    1
  • Ya-Xin Wang

    Search for this expert
    1
  • Ji-Qain Xu

    Search for this expert
    1
  • Ya-Jun He

    Search for this expert
    1
  • Zhe-Kang Peng

    Search for this expert
    1
  • You Shang

    Search for this expert
    1

Abstract

COVID-19 is an acute, complex disorder that was caused by a new β-coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Based on current reports, it was surprising that the characteristics of many patients with COVID-19, who fulfil the Berlin criteria for acute respiratory distress syndrome (ARDS), are not always like those of patients with typical ARDS and can change over time. While the mechanisms of COVID-19-related respiratory dysfunction in COVID-19 have not yet been fully elucidated, pulmonary microvascular thrombosis is speculated to be involved. Considering that thrombosis is highly related to other inflammatory lung diseases, immunothrombosis, a two-way process that links coagulation and inflammation, seems to be involved in the pathophysiology of COVID-19, including respiratory dysfunction. Thus, the current manuscript will describe the proinflammatory milieu in COVID-19, summarize current evidence of thrombosis in COVID-19, and discuss possible interactions between these two.

References

Thromb Res. 2010 Feb;125(2):159-65

BMJ. 2003 Jun 21;326(7403):1358-62

Nature. 2020 Mar;579(7798):270-273

Am J Respir Crit Care Med. 2020 May 15;201(10):1299-1300

Cited by 24 citations (total)

Journal Article Review

Dysregulated miRNAs network in the critical COVID-19: An important clue for uncontrolled immunothrombosis/thromboinflammation.

Electronic publication date August 18, 2022

Search for publications in this journal Int Immunopharmacol

Seyed Shahabeddin Mortazavi-Jahromi [...] Mona Aslani et al.

Known as a pivotal immunohemostatic response, immunothrombosis is activated to restrict the diffusion of pathogens. This beneficial intravascular defensive mechanism...

Journal Article

The timing of intubation and principles of ICU care in COVID-19

Electronic publication date December 30, 2021

Search for publications in this journal Turk J Med Sci

Sema Turan [...] Levent Yamanel et al.

Coronavirus disease-19 (COVID-19) has been a serious health problem since it was first identified in Wuhan, China, in December 2019...

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

MeSH

Specialties

Copyright

Copyright © 2021 Fang, Wang, Xu, He, Peng and Shang.